Frontiers in Immunology (Oct 2024)
Editorial: Tumor microenvironment and metabolic reprogramming in cancer
- Xiaoling Cui,
- Xiaoling Cui,
- Xiaoling Cui,
- Xinyu Liu,
- Xinyu Liu,
- Xinyu Liu,
- Rongjie Feng,
- Xiaohan Wang,
- Xiaohan Wang,
- Xiaohan Wang,
- Yiju Wei,
- Yiju Wei,
- Houjuan Zhu,
- Asif Raza,
- Xingyu Zhu,
- Xingyu Zhu,
- Xingyu Zhu,
- Hao Chen,
- Wei Chong,
- Wei Chong,
- Wei Chong
Affiliations
- Xiaoling Cui
- Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
- Xiaoling Cui
- Shandong Provincial Laboratory of Translational Medicine Engineering for Digestive Tumors, Shandong Provincial Hospital, Jinan, China
- Xiaoling Cui
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China
- Xinyu Liu
- Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
- Xinyu Liu
- Shandong Provincial Laboratory of Translational Medicine Engineering for Digestive Tumors, Shandong Provincial Hospital, Jinan, China
- Xinyu Liu
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China
- Rongjie Feng
- Department of Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
- Xiaohan Wang
- Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
- Xiaohan Wang
- Shandong Provincial Laboratory of Translational Medicine Engineering for Digestive Tumors, Shandong Provincial Hospital, Jinan, China
- Xiaohan Wang
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China
- Yiju Wei
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China
- Yiju Wei
- School of Life Science, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China
- Houjuan Zhu
- Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore
- Asif Raza
- Department of Pharmacology, Penn State Cancer Institute, The Pennsylvania State University College of Medicine, Hershey, PA, United States
- Xingyu Zhu
- Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
- Xingyu Zhu
- Shandong Provincial Laboratory of Translational Medicine Engineering for Digestive Tumors, Shandong Provincial Hospital, Jinan, China
- Xingyu Zhu
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China
- Hao Chen
- Clinical Research Center of Shandong University, Clinical Epidemiology Unit, Qilu Hospital of Shandong University, Jinan, China
- Wei Chong
- Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
- Wei Chong
- Shandong Provincial Laboratory of Translational Medicine Engineering for Digestive Tumors, Shandong Provincial Hospital, Jinan, China
- Wei Chong
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China
- DOI
- https://doi.org/10.3389/fimmu.2024.1497966
- Journal volume & issue
-
Vol. 15
Abstract
No abstracts available.Keywords
